No Data
Is Shanghai Haoyuan Chemexpress (SHSE:688131) Using Too Much Debt?
Haoyuan Pharmaceutical (688131.SH) plans to distribute 1.5 yuan for every 10 shares to 4 shares in 2023, excluding interest on June 27
In its announcement, Hao Yuan Pharmaceutical (688131.SH) stated that it plans to distribute cash to all shareholders in the amount of 10 shares per dividend for the year 2023.
Haoyuan Medicine (688131.SH): The actual controller and its concerted action parties renewed the "Concerted Action Agreement".
On June 7th, Gelunhui reported that Haoyuan Pharmaceutical (688131.SH) received a notice from Mr. Zheng Baofu, the actual controller of the company, Mr. Gao Qiang, Mr. Li Shuoliang, the unified action person with them, and Ms. Liu Yishan, regarding the renewal of the "Unified Action Agreement." Given that the "Unified Action Agreement" signed by all parties prior to the company's initial public offering of stocks is about to expire, in order to improve corporate governance, ensure the continuity and stability of company operations, and achieve substantial and effective control of the company, the aforementioned parties have renewed the "Unified Action Agreement."
Haoyuan Pharmaceutical (688131.SH) will list and circulate 598.38 million restricted shares starting June 11
Haoyuan Pharmaceutical (688131.SH) issued an announcement. The restricted shares in circulation in this listing are part of the company's initial public offering...
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Market Cap Dropped CN¥380m Last Week; Private Companies Bore the Brunt
Haoyuan Pharmaceutical (688131.SH)'s net profit for the first quarter of 167.574 million yuan decreased by 63.76% year-on-year
Gelonghui, April 29丨Haoyuan Pharmaceutical (688131.SH) released its report for the first quarter of 2024. Operating revenue during the reporting period was 505 million yuan, up 20.68% year on year; net profit attributable to shareholders of listed companies was 16.7574 million yuan, a year-on-year decrease of 63.76%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 13.922,300 yuan, a year-on-year decrease of 66.82%, with basic earnings per share of 0.11 yuan.
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) P/E Is Still On The Mark Following 31% Share Price BounceNo Data
